The Vicorder device compared with SphygmoCor in the assessment of carotid-femoral pulse wave velocity in patients with peripheral arterial disease

Hypertension Research

Volumn 36, Issue 3, 2013, Pages 208-212

  Shahin, Yousef ^a   Barakat, Hashem ^a   Barnes, Rachel ^a   Chetter, Ian ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

arterial stiffness; peripheral arterial disease; pulse wave velocity; sphygmoCor; vicorder device

Indexed keywords

ADULT; ANALYZER; ARTERIAL STIFFNESS; ARTICLE; BLOOD FLOW; CAROTID FEMORAL PULSE WAVE VELOCITY; CLINICAL ARTICLE; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTRARATER RELIABILITY; MALE; MEASUREMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PULSE WAVE; REPRODUCIBILITY;

AGED; CAROTID ARTERIES; EQUIPMENT AND SUPPLIES; FEMALE; FEMORAL ARTERY; HUMANS; MALE; MANOMETRY; MIDDLE AGED; OBSERVER VARIATION; OSCILLOMETRY; PERIPHERAL ARTERIAL DISEASE; PULSE WAVE ANALYSIS; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 84874625089     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2012.144     Document Type: Article

References (19)

1. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003; 107: 2864-2869.
2. London GM, Marchais SJ, Guerin AP, Pannier B. Arterial stiffness: pathophysiology and clinical impact. Clin Exp Hypertens 2004; 26: 689-699.
3. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241.
4. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434-2439.
5. Arnett DK, Evans GW, Riley WA. Arterial stiffness: a new cardiovascular risk factor Am J Epidemiol 1994; 140: 669-682.
6. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588-2605.
7. Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Cockcroft JR, Webb DJ. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 1998; 16: 2079-2084.
8. Frimodt-Moller M, Nielsen AH, Kamper AL, Strandgaard S. Reproducibility of pulsewave analysis and pulse-wave velocity determination in chronic kidney disease. Nephrol Dial Transplant 2008; 23: 594-600.
9. Hickson SS, Butlin M, Broad J, Avolio AP, Wilkinson IB, McEniery CM. Validity and repeatability of the Vicorder apparatus: a comparison with the SphygmoCor device. Hypertens Res 2009; 32: 1079-1085.
10. Millasseau SC, Stewart AD, Patel SJ, Redwood SR, Chowienczyk PJ. Evaluation of carotid-femoral pulse wave velocity: influence of timing algorithm and heart rate. Hypertension 2005; 45: 222-226.
11. Rajzer MW, Wojciechowska W, Klocek M, Palka I, Brzozowska-Kiszka M, Kawecka-Jaszcz K. Comparison of aortic pulse wave velocity measured by three techniques: Complior, SphygmoCor and Arteriograph. J Hypertens 2008; 26: 2001-2007.
12. van Leeuwen-Segarceanu EM, Tromp WF, Bos WJ, Vogels OJ, Groothoff JW, van der Lee JH. Comparison of two instruments measuring carotid-femoral pulse wave velocity: Vicorder versus SphygmoCor. J Hypertens 2010; 28: 1687-1691.
13. Kis E, Cseprekal O, Kerti A, Salvi P, Benetos A, Tisler A, Szabo A, Tulassay T, Reusz GS. Measurement of pulse wave velocity in children and young adults: a comparative study using three different devices. Hypertens Res 2011; 34: 1197-1202.
14. Kracht D, Shroff R, Baig S, Doyon A, Jacobi C, Zeller R, Querfeld U, Schaefer F, Wuhl E, Schmidt BM, Melk A. Validating a new oscillometric device for aortic pulse wave velocity measurements in children and adolescents. Am J Hypertens 2011; 24: 1294-1299.
15. Jones CR, Taylor K, Poston L, Shennan AH. Validation of the Welch Allyn 'Vital Signs' oscillometric blood pressure monitor. J Hum Hypertens 2001; 15: 191-195.
16. Alpert BS. Validation of the Welch Allyn Spot Vital Signs blood pressure device according to the ANSI/AAMI SP10: 2002. Accuracy and cost-efficiency successfully combined. Blood Press Monit 2007; 12: 345-347.
17. Davis PD, Dennis JL, Railton R. Evaluation of the A&D UA-767 and Welch Allyn Spot Vital Signs noninvasive blood pressure monitors using a blood pressure simulator. J Hum Hypertens 2005; 19: 197-203.
18. Papaioannou TG, Karatzis EN, Karatzi KN, Gialafos EJ, Protogerou AD, Stamatelopoulos KS, Papamichael CM, Lekakis JP, Stefanadis CI. Hour-to-hour and week-to-week variability and reproducibility of wave reflection indices derived by aortic pulse wave analysis: implications for studies with repeated measurements. J Hypertens 2007; 25: 1678-1686.
19. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.